Press release
Pneumococcal Vaccine Market Industry Share, Growth, Segments and Forecast - 2031
The global pneumococcal vaccine market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market includes the increasing efforts to curb pneumonia among children in developed countries. Whereas, in the developing countries, the increasing spending on infrastructure and rising awareness towards vaccines, are the factors, which are expected to fuel the market growth during the forecasted period.Get Free Sample link @ https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market-share
According to the report by Jon Hopkins, in 2019, 5 million children died before reaching the age of 5 years, out of which around 25% of children died due to pneumonia or diarrhoea. The developing countries in Asia and Africa contribute to around 70% of the global death burden of children due to pneumonia. GAVI (the vaccine alliance) is working towards vaccinating these children who are living in emerging economies. For many countries including the UK, Canada, Russia, Norway, Bill Gates and Melinda Gates Foundation had contributed around $1.5 billion towards the program. By the end of 2018, more than 183 million children were given shot of the vaccine against pneumococcal.
Some of the key global market players include Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL Ltd., and Astellas Pharma Inc. In June 2020, the Serum Institute of India started supplying vaccines for $2 as compared to $3.5 per dose earlier. The company had agreed to provide 10 million doses per year to the countries which are supported by GAVI for the next 10 years.
Full report of Pneumococcal Vaccine Market available @ https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market-share
Market Coverage
Segment Covered-
o By Vaccine Type
o By Distribution Channel
o By Type
o By Age Group
Competitive Landscape - Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL Ltd., among others
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Pneumococcal Vaccine Market by Segment
o By Vaccine Type
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
o By Distribution Channel
Public
Private
o By Type
Branded
Generic
o By Age Group
Children
Adult
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pneumococcal-vaccine-market-share
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccine Market Industry Share, Growth, Segments and Forecast - 2031 here
News-ID: 3689203 • Views: …
More Releases from Orion Market Research

Cyber Security Insurance Market - Current Impact to Make Big Changes by 2033
The Cyber Security Insurance (Cyber Insurance) Market was valued at approximately USD 15.87 billion in 2023 and is projected to reach USD 90.6 billion by 2033, reflecting a CAGR of about 22.3% from 2024 to 2033.
Cyber Security Insurance Market Overview
The Cyber Insurance Market is experiencing extraordinary momentum as organizations increasingly recognize the financial and reputational risks posed by cyber threats. Fueled by growing digital transformation and rising ransomware, data breaches,…

On-Demand Home Services Market: A Guide to Understanding the Process
The On-Demand Home Services Market was valued at approximately USD 5.17 billion in 2023 and is projected to grow to around USD 236 billion by 2033, reflecting a CAGR of about 5.9% from 2025 to 2033.
On-Demand Home Services Market Overview
The On-Demand Home Services Market is witnessing strong growth as consumers increasingly turn to digital platforms for convenient and efficient household solutions such as cleaning, maintenance, beauty, and appliance repair. This…

Oil Shale Market Global Rising Demand & Huge Scope Till 2033
The Oil Shale Market was valued at approximately USD 3.54 billion in 2023 and is anticipated to grow to around USD 9.21 billion by 2033, reflecting a CAGR of about 8.15% from 2024 to 2033.
Oil Shale Market Overview
The Oil Shale Market is experiencing steady growth, driven by the rising global demand for energy, the depletion of conventional fossil fuel reserves, and the increasing emphasis on energy security. North America leads…

Consumer IAM Market Share: In-Depth Analysis, Growth Opportunities, Key Trends, …
The Consumer IAM Market was valued at approximately USD 10.08 billion in 2023 and is projected to reach USD 46.55 billion by 2033, reflecting a CAGR of about 16.5% from 2024 to 2033.
Consumer IAM Market Overview
The Consumer Identity and Access Management (Consumer IAM) Market is witnessing strong growth, driven by the increasing need for secure, seamless, and user-friendly digital interactions across industries such as banking, retail, healthcare, and telecommunications.…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…